CEACAM6 and acute lymphoblastic leukemia: BCP-ALL cells can be distinguished from normal B-cells by abnormal expression of known maturation makers (e.g., CD10, CD20, CD34, and CD45) combined with aberrant expression of other markers (e.g., CD58, CD81, CD304, CD73, CD66c, and CD123).